BR0311804A - 1-phenylalkyl piperazine - Google Patents

1-phenylalkyl piperazine

Info

Publication number
BR0311804A
BR0311804A BR0311804-5A BR0311804A BR0311804A BR 0311804 A BR0311804 A BR 0311804A BR 0311804 A BR0311804 A BR 0311804A BR 0311804 A BR0311804 A BR 0311804A
Authority
BR
Brazil
Prior art keywords
optionally substituted
alkyl
thiocarbonyl
group
aryl
Prior art date
Application number
BR0311804-5A
Other languages
Portuguese (pt)
Inventor
Amadeo Leonardi
Gianni Motta
Carlo Riva
Elena Poggesi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of BR0311804A publication Critical patent/BR0311804A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"1-FENIL-ALQUIL-PIPERAZINAS". Descreve-se compostos da fórmula (I) (R e R~ 1~ são uma ampla série de substituintes, Q é CO, CHOH ou CHOR~ 2~, R~ 2~ é um grupo alquila, alquenila ou ciclo-alquila, cada um sendo opcionalmente substituído ou é alcanoíla, alcanoilóxi, amino-carbonila, alquil-amino-carbonila, dialquil-amihocarbonila, amino-tiocarbonila, alquil-amino-tiocarbonila ou dialquil-amino-tiocarbonila, R~ 3~ é H, um grupo alquila, alquenila, alquinila, ciclo-alquila, arila ou heterociclo, cada um dos quais sendo opcionalmente substituído, n é 1 ou 2, A é uma ligação ou um grupo metileno ou etileno, e R~ 4~ é um grupo arila ou heteroarila, qualquer um dos dois sendo opcionalmente substituído), que têm afinidade por receptores serotoninérgicos. Estes compostos e seus enanciómeros, diastereoisómeros, N-óxidos de piperazina, polimorfos, solvatos e sais farmaceuticamente aceitáveis, são úteis no tratamento de pacientes com disfunção neuromuscular do trato urinário inferior e doenças relacionadas à atividade de receptores de 5-HT~ 1A~."1-FENIL-ALKYL-PIPERAZINES". Compounds of formula (I) are described. (R and R 1 - are a wide range of substituents, Q is CO, CHOH or CHOR 2 -, R 2 - is an alkyl, alkenyl or cycloalkyl group each optionally substituted being either alkanoyl, alkanoyloxy, aminocarbonyl, alkylamino carbonyl, dialkyl amiocarbonyl, amino thiocarbonyl, alkylamino thiocarbonyl or dialkylamino thiocarbonyl, R 3 is H, an alkyl group alkenyl, alkynyl, cycloalkyl, aryl or heterocycle, each of which being optionally substituted, n is 1 or 2, A is a bond or a methylene or ethylene group, and R 4 is an aryl or heteroaryl group, either being optionally substituted), which have affinity for serotonergic receptors. These compounds and their pharmaceutically acceptable enantiomers, diastereoisomers, piperazine N-oxides, polymorphs, solvates and salts are useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and diseases related to 5-HT 1A receptor activity.

BR0311804-5A 2002-06-14 2003-06-16 1-phenylalkyl piperazine BR0311804A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI001327A ITMI20021327A1 (en) 2002-06-14 2002-06-14 NEW OSSIALCHILPIPERAZINE
PCT/EP2003/006289 WO2003106443A1 (en) 2002-06-14 2003-06-16 1-phenylalkyl-piperazines

Publications (1)

Publication Number Publication Date
BR0311804A true BR0311804A (en) 2005-03-29

Family

ID=29727276

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311804-5A BR0311804A (en) 2002-06-14 2003-06-16 1-phenylalkyl piperazine

Country Status (19)

Country Link
EP (1) EP1549627A1 (en)
JP (1) JP2006502102A (en)
KR (1) KR20050055628A (en)
CN (1) CN1659155A (en)
AU (1) AU2003246434A1 (en)
BR (1) BR0311804A (en)
CA (1) CA2489449A1 (en)
EA (1) EA200500024A1 (en)
HR (1) HRP20050033A2 (en)
IL (1) IL165569A0 (en)
IT (1) ITMI20021327A1 (en)
MX (1) MXPA04012489A (en)
NO (1) NO20050147L (en)
NZ (1) NZ537470A (en)
PL (1) PL372702A1 (en)
RS (1) RS109004A (en)
TW (1) TW200406394A (en)
WO (1) WO2003106443A1 (en)
ZA (1) ZA200500317B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071197B2 (en) * 2002-06-14 2006-07-04 Recordati S.A. N,N-disubstituted diazocycloalkanes
US7365076B2 (en) * 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
WO2008140197A1 (en) * 2007-05-14 2008-11-20 Sk Holdings Co., Ltd. Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
EP3113768B1 (en) * 2014-03-05 2018-09-26 Universita' Degli Studi Di Pavia Use of arylalkanolamines as sigma-1 receptor antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826348B2 (en) * 1974-07-01 1983-06-02 住友化学工業株式会社 Method for producing new benzisoxazole derivatives
DE3318577A1 (en) * 1982-05-25 1983-12-01 Fordonal S.A., Madrid Piperazine derivatives
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
JP3523887B2 (en) * 1992-03-09 2004-04-26 武田薬品工業株式会社 Condensed heterocyclic ketone derivative, production method thereof, intermediate and agent
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
GB9514384D0 (en) * 1995-07-13 1995-09-13 American Home Prod Medical treatment
UA66370C2 (en) * 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors

Also Published As

Publication number Publication date
WO2003106443A1 (en) 2003-12-24
AU2003246434A1 (en) 2003-12-31
NO20050147L (en) 2005-03-14
EP1549627A1 (en) 2005-07-06
ITMI20021327A1 (en) 2003-12-15
NO20050147D0 (en) 2005-01-11
PL372702A1 (en) 2005-07-25
RS109004A (en) 2007-02-05
EA200500024A1 (en) 2005-06-30
JP2006502102A (en) 2006-01-19
MXPA04012489A (en) 2005-06-08
KR20050055628A (en) 2005-06-13
ZA200500317B (en) 2006-11-29
NZ537470A (en) 2006-06-30
HRP20050033A2 (en) 2006-11-30
CA2489449A1 (en) 2003-12-24
TW200406394A (en) 2004-05-01
IL165569A0 (en) 2006-01-15
CN1659155A (en) 2005-08-24

Similar Documents

Publication Publication Date Title
BR0009007A (en) Piperidine derivatives, epiperazine tetrahydropyridine; compound; pharmaceutical composition, use and method
BR9806413A (en) Compound and use thereof
TW200517109A (en) Substituted pyridinones
BRPI0413232A (en) novel compounds having inhibitory activity against sodium-dependent transporters
MXPA05010621A (en) Substituted pyrimidinones.
BRPI0509307A (en) alpha aryl or heteroaryl methyl beta piperidine propanamide compounds as orl1 receptor antagonists
MXPA04007470A (en) Substituted pyridinones as modulators of p38 map kinase.
NO914827D0 (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC AMINES
HUP0204246A2 (en) Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use
TR199900255T2 (en) Muscarinic antagonists
TW200716528A (en) Cyclopropanecarboxamide derivatives
HK1110868A1 (en) Heterocyclic compounds as ccr2b antagonists
DE60211343D1 (en) DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND TRIAZOLYLPURINE AS LIGANDE OF ADENOSINE A2A RECEPTORS AND THEIR USE AS MEDICAMENTS
BRPI0508180A (en) 1,3,4-oxadiazol-2-ones as delta p modulators and their use thereof
DE3065304D1 (en) Morpholine derivatives, pharmaceutical compositions containing them and processes for their preparation
EA200400936A1 (en) Heteroaryl-substituted derivatives of 2-pyridine-2 and pyrimidinyl-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidine-4-it
MY139461A (en) Condensed furan compounds
MY133108A (en) Muscarinic antagonists
YU53100A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
IS8096A (en) Use of carbamazepine derivatives to treat patient agitation is dementia sufferers
BR0311804A (en) 1-phenylalkyl piperazine
KR920019796A (en) 1- (pyrido [3,4-b] -1,4-oxazinyl-4-yl) -1H-indole, intermediates thereof and methods for their preparation, and their use as medicaments
ID16091A (en) ARRIVAL 3,4-SUBSTITUTION OF PHENILETANOLAMINOTETRALIN CARBOXAMIDE
BR0207433A (en) Isoxazoline derivatives as antidepressants
NO972938L (en) Pharmaceutical piperazine compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.